-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
U.S. Stem Cell, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2022.
- U.S. Stem Cell, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2022 was -$192K, a 30.9% increase year-over-year.
- U.S. Stem Cell, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2022 was -$1.14M, a 1.22% increase year-over-year.
- U.S. Stem Cell, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.14M, a 1.22% increase from 2021.
- U.S. Stem Cell, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.15M, a 135% decline from 2020.
- U.S. Stem Cell, Inc. annual Nonoperating Income (Expense) for 2020 was -$490K, a 17.2% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)